La vendita allo scoperto per Stellantis dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Stellantis. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Stellantis (NYSE:STLA) Azioni, Report sulle vendite allo scoperto

Stellantis

Stellantis was created out of the merger of US-based Fiat Chrysler Automobiles, or FCA, and French-based Peugeot, or PSA, in January 2021, resulting in the fourth-largest automotive original equipment manufacturer, or OEM, by vehicle sales. In 2023 it sold 6.4 million vehicles, 44% and 30% in Europe and North America, respectively. North America is the most profitable region, contributing 53% of operating income. Its brands include Fiat, Jeep, Chrysler, Ram, Peugeot, Citroen, Opel, Alfa Romeo, and Maserati.

News

Global

Tech

Media

STLA

Stellantis interrompe la produzione della Fiat 500e per 4 settimane a Torino: domanda bassa e difficoltà nel mercato europeo.

Stellantis sospende la produzione della Fiat 500e: non si vende

General

Indagine NHTSA su oltre 780.000 veicoli Stellantis per rischio incendio. Coinvolti modelli Jeep Wrangler, Gladiator e Ram.

Jeep e non solo: richiamati veicoli Stellantis a rischio incendio

Stellantis NV

Offerings

ARQQ

Arqit Quantum Announces $13.6M Registered Direct Offering Of 5.44M Shares At $2.50/Share

<h3>Gainers</h3>
<ul>
<li>Linkage Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCB#NASDAQ">LGCB</a>) stock increased by 5.0% to $0.38 during Monday's after-market session. The market value of their outstanding shares is at $8.1 million. </li>
<li>Volcon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares increased by 4.8% to $1.09. The market value of their outstanding shares is at $5.0 million. </li>
<li>ATA Creativity Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AACG#NASDAQ">AACG</a>) shares rose 4.25% to $0.8. The company's market cap stands at $25.5 million. </li>
<li>Algorhythm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) stock increased by 4.16% to $0.49. The company's market cap stands at $4.7 million. </li>
<li>Kaixin Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>) shares increased by 4.04% to $0.2. The market value of their outstanding shares is at $12.1 million. </li>
<li>TCTM Kids IT Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCTM#NASDAQ">TCTM</a>) shares increased by 2.94% to $1.4. The market value of their outstanding shares is at $13.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>PLBY Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBY#NASDAQ">PLBY</a>) stock declined by 5.0% to $0.72 during Monday's after-market session. The market value of their outstanding shares is at $53.2 million. </li>
<li>ZHONGCHAO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCMD#NASDAQ">ZCMD</a>) stock fell 4.88% to $2.34. The market value of their outstanding shares is at $5.8 million. </li>
<li>Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) stock fell 4.73% to $2.22. The company's market cap stands at $43.6 million. </li>
<li>Lotus Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOT#NASDAQ">LOT</a>) shares fell 3.56% to $4.89. The market value of their outstanding shares is at $3.3 billion. </li>
<li>Vroom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRM#NASDAQ">VRM</a>) stock declined by 3.53% to $9.04. The market value of their outstanding shares is at $16.4 million. </li>
<li>Lottery.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) shares declined by 3.29% to $0.58. The market value of their outstanding shares is at $5.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AACG

KXIN

LGCB

LTRY

PLBY

RIME

TCTM

VLCN

ZCMD

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Repare Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>) stock increased by 13.4% to $3.9 during Monday's after-market session. The company's market cap stands at $165.5 million. </li>
<li>Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) shares moved upwards by 10.45% to $0.52. The company's market cap stands at $20.7 million. </li>
<li>Singular Genomics Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMIC#NASDAQ">OMIC</a>) shares rose 9.76% to $17.2. The company's market cap stands at $42.9 million. </li>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) shares increased by 5.81% to $0.74. The company's market cap stands at $50.6 million. </li>
<li>Bionano Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNGO#NASDAQ">BNGO</a>) stock moved upwards by 5.75% to $0.48. The market value of their outstanding shares is at $41.2 million. </li>
<li>Quantum-Si (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) shares increased by 5.41% to $0.93. The company's market cap stands at $132.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>IGM Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGMS#NASDAQ">IGMS</a>) shares decreased by 15.4% to $14.0 during Monday's after-market session. The market value of their outstanding shares is at $830.4 million. </li>
<li>Karyopharm Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPTI#NASDAQ">KPTI</a>) stock decreased by 9.4% to $0.75. The market value of their outstanding shares is at $93.7 million. </li>
<li>Pennant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNTG#NASDAQ">PNTG</a>) stock decreased by 7.57% to $33.0. The company's market cap stands at $996.8 million. </li>
<li>Apollomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLM#NASDAQ">APLM</a>) stock decreased by 6.26% to $0.13. The market value of their outstanding shares is at $14.6 million. </li>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) stock decreased by 5.0% to $0.65. The company's market cap stands at $6.5 million. </li>
<li>Cue Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUE#NASDAQ">CUE</a>) stock decreased by 5.0% to $0.72. The market value of their outstanding shares is at $34.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APLM

BNGO

CGTX

IGMS

KPTI

NIVF

OMIC

PNTG

RPTX

12 Health Care Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Professional Diversity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPDN#NASDAQ">IPDN</a>) stock rose 13.6% to $0.5 during Monday's after-market session. The market value of their outstanding shares is at $6.3 million. </li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) stock rose 11.11% to $0.79. The company's market cap stands at $4.7 million. </li>
<li>New Horizon Aircraft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOVR#NASDAQ">HOVR</a>) stock moved upwards by 8.07% to $0.5. The company's market cap stands at $10.6 million. </li>
<li>Knightscope (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) shares increased by 4.75% to $7.71. The company's market cap stands at $23.5 million. </li>
<li>Guardforce AI Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFAI#NASDAQ">GFAI</a>) stock increased by 4.09% to $1.27. The company's market cap stands at $13.0 million. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATIF#NASDAQ">ATIF</a>) shares rose 4.04% to $1.03. The company's market cap stands at $12.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>ShiftPixy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIXY#NASDAQ">PIXY</a>) shares decreased by 15.6% to $0.7 during Monday's after-market session. The company's market cap stands at $5.2 million. </li>
<li>Lakeside Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSH#NASDAQ">LSH</a>) stock declined by 12.68% to $3.17. The company's market cap stands at $22.9 million. </li>
<li>Volato Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SOAR#AMEX">SOAR</a>) stock decreased by 7.63% to $0.36. The company's market cap stands at $10.6 million. </li>
<li>Wheels Up Experience (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UP#NYSE">UP</a>) stock decreased by 5.38% to $2.29. The market value of their outstanding shares is at $1.5 billion. </li>
<li>flyExclusive (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FLYX#AMEX">FLYX</a>) shares fell 4.03% to $2.86. The company's market cap stands at $223.4 million. </li>
<li>Roma Green Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROMA#NASDAQ">ROMA</a>) shares decreased by 3.82% to $0.72. The market value of their outstanding shares is at $11.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATIF

ATXG

FLYX

GFAI

HOVR

IPDN

KSCP

PIXY

ROMA

SOAR

12 Industrials Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Glimpse Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>) stock rose 8.5% to $0.82 during Monday's after-market session. The market value of their outstanding shares is at $14.8 million. As per the news, the Q4 earnings report came out today. </li>
<li>Next Technology Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) stock moved upwards by 7.37% to $1.31. The company's market cap stands at $9.1 million. </li>
<li>ReposiTrak (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRAK#NYSE">TRAK</a>) shares moved upwards by 5.84% to $19.55. The company's market cap stands at $356.2 million. As per the news, the Q4 earnings report came out today. </li>
<li>Argo Blockchain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) shares moved upwards by 5.78% to $1.28. The company's market cap stands at $81.4 million. </li>
<li>Greenidge Generation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GREE#NASDAQ">GREE</a>) shares moved upwards by 5.51% to $1.91. The company's market cap stands at $20.3 million. </li>
<li>Daktronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAKT#NASDAQ">DAKT</a>) stock rose 4.33% to $13.47. The market value of their outstanding shares is at $623.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares declined by 23.3% to $0.09 during Monday's after-market session. The market value of their outstanding shares is at $1.5 million. </li>
<li>CPI Card (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMTS#NASDAQ">PMTS</a>) stock declined by 8.45% to $25.48. The market value of their outstanding shares is at $281.9 million. </li>
<li>BIT Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTCM#NYSE">BTCM</a>) shares decreased by 6.39% to $2.2. The market value of their outstanding shares is at $24.4 million. </li>
<li>Intchains Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) stock declined by 5.6% to $4.22. The company's market cap stands at $253.2 million. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) stock decreased by 5.02% to $0.24. The market value of their outstanding shares is at $4.3 million. </li>
<li>BIO-key Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) stock declined by 5.0% to $0.91. The market value of their outstanding shares is at $2.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARBK

BKYI

BTCM

CETX

DAKT

GREE

Next Technology Holding Inc. - Ordinary Shares

NXTT

PMTS

TRAK

VRAR

12 Information Technology Stocks Moving In Monday's After-Market Session

United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) has outperformed the market over the past 15 years by 2.84% on an annualized basis producing an average annual return of 14.79%. Currently, United Airlines Holdings has a market capitalization of $18.76 billion. 
Buying $100 In UAL: If an investor had bought $100 of UAL stock 15 years ago, it would be worth $781.64 today based on a price of $57.06 for UAL at the time of writing.
<h3>United Airlines Holdings's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727728240_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning United Airlines Holdings Stock In The Last 15 Years

Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) has outperformed the market over the past 10 years by 3.25% on an annualized basis producing an average annual return of 14.74%. Currently, Guidewire Software has a market capitalization of $15.12 billion. 
Buying $100 In GWRE: If an investor had bought $100 of GWRE stock 10 years ago, it would be worth $393.59 today based on a price of $182.94 for GWRE at the time of writing.
<h3>Guidewire Software's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727728235_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GWRE

Here's How Much $100 Invested In Guidewire Software 10 Years Ago Would Be Worth Today

Global Payments's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) short percent of float has risen 16.47% since its last report. The company recently reported that it has 7.53 million shares sold short, which is 2.97% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.98 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Global Payments Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727728224_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Global Payments has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Global Payments's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Global Payments's peer group average for short interest as a percentage of float is 5.78%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Global Payments?

APA's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APA#NYSE">APA</a>) short percent of float has risen 26.02% since its last report. The company recently reported that it has 16.92 million shares sold short, which is 5.23% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.06 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>APA Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727728219_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for APA has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing APA's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, APA's peer group average for short interest as a percentage of float is 6.58%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(APA) - Analyzing APA's Short Interest

Ulta Beauty's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NYSE">ULTA</a>) short percent of float has fallen 10.66% since its last report. The company recently reported that it has 2.88 million shares sold short, which is 7.88% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.36 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Ulta Beauty Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727728214_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ulta Beauty has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Ulta Beauty's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Ulta Beauty's peer group average for short interest as a percentage of float is 12.70%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

ULTA

(ULTA) - Analyzing Ulta Beauty's Short Interest

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/BLGVF">Belgravia Hartford Cap</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLGVF#OTC">BLGVF</a>) shares closed up 22.31% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 19.33% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 12.97% at $2.70</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 6.06% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 5.04% at $4.82</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 4.26% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNPOF">RIV Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed up 4.17% at $0.15</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed up 3.90% at $11.19</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 3.72% at $0.93</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 3.31% at $2.50</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/AUSAF">Australis Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AUSAF#OTC">AUSAF</a>) shares closed down 99.01% at $0.0001</li>
<li><a href="https://www.benzinga.com/quote/CHOOF">Choom Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CHOOF#OTC">CHOOF</a>) shares closed down 90.00% at $1e-06</li>
<li><a href="https://www.benzinga.com/quote/GRNH">GreenGro Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GRNH#OTC">GRNH</a>) shares closed down 90.00% at $1e-06</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 14.92% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 13.69% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 12.28% at $0.22</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 9.09% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">Cansortium</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 7.11% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed down 6.98% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Props</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed down 6.89% at $0.54</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 5.76% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 3.70% at $0.01</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

AUSAF

BLGVF

CHOOF

CNPOF

CNTMF

CPHRF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

ELLXF

FFNTF

FUAPF

GRNH

ITHUF

KAYS

LMLLF

NWVCF

OILFF

TGIFF

XXII

ZDPY

Bearish Monday For Marijuana Stocks - Australis Capital, Choom Holdings Among Top Gainers

Fidelity was one of several companies that helped Elon Musk acquire social media platform X, formerly known as Twitter, back in 2022. The financial company may have lost money on their investment in the company according to recent valuation metrics, which show the <a href="https://www.benzinga.com/m-a/22/10/29458281/elon-musk-takes-over-twitter-whos-in-charge-whos-gone-and-what-happens-to-the-stock">$44 billion paid by Musk</a> may have been too high.
What Happened: Fidelity owns a stake in X in the Fidelity Blue Chip Growth Fund (FBGRX) and changes the valuation of the social media company periodically<a href="https://www.benzinga.com/news/24/02/36895228/fidelity-raises-x-valuation-heres-how-much-its-fallen-from-elon-musks-twitter-purchase-price"> to reflect valuations</a> based on financials and peer companies.
With X facing concerns <a href="https://www.benzinga.com/news/24/09/40724275/elon-musks-x-faces-26-ad-spend-decline-by-2025-amid-steep-decline-in-brand-safety-survey-reveals">over advertising revenue</a>, the stake valuation has often been lowered, with some months showing a higher valuation from the mutual fund.
The latest fund valuation shows the Fidelity Blue Chip Growth Fund having a <a href="https://fundresearch.fidelity.com/mutual-funds/view-all/316389303">stake </a>in X worth $4.19 million as of the end of August, as <a href="https://techcrunch.com/2024/09/29/fidelity-has-cut-xs-value-by-79-since-musk-purchase/">reported </a>by TechCrunch.
Fidelity valued the stake at $5.5 million at the end of July, marking another reduction in valuation for August.
For context, Fidelity initially invested $19.66 million in X through its mutual fund. Following the latest valuation cut, Fidelity now values its stake at 78.7% below the original investment.
With its latest valuation revision, Fidelity assigns a valuation of $9.4 billion. This marks a significant decline from Musk's $44 purchase price.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent093024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: Musk has recognized that he likely <a href="https://www.benzinga.com/m-a/22/10/29334819/elon-musk-sees-long-term-potential-in-twitter-despite-obviously-overpaying-for-it">overpaid for Twitter </a>over the years, but he also has grand plans to turn the company into his vision of an everything app that will include social media connections, video, and financial payments.
After paying $44 billion for the company, Musk may have hurt the valuation by offering a lower price point on stock awards for employees.
Months later, Twitter was valued at $20 billion when stock awards for the company&#8217;s employees were announced in March 2023. While the valuation of the stock awards was less than half of the price Musk paid, the then-CEO said he was optimistic about the company.
"I see a clear, but difficult, path to a &lt;$250B valuation," Musk said at the time.
For Fidelity, the loss on the X investment may be minor, with the Fidelity Blue Chip Growth Fund mutual fund having a small stake in the company. The fund invests in private and public companies and is likely helped by the fact that the largest holdings in the fund are currently NVIDIA Corporation (13.4%), Apple (11.8%), Microsoft (8.2%), Amazon.com (8.1%) and Alphabet (6.1%).
Along with its stake in privately held X Holdings, the Fidelity Blue Chip Growth Fund also owns stakes in some of the most well-known private companies like SpaceX, Fanatics, Stripe, Epic Games, Redwood Materials, MOD Pizza and Relativity Space.
Ark Funds, which <a href="https://www.benzinga.com/news/22/11/29524537/cathie-wood-invested-in-musks-twitter-takeover-how-you-can-get-a-stake-for-500">owns a stake</a> in X Holdings via the Ark Venture Fund, has also often changed the valuation for its stake in the social media company.
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent093024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Photo: Shutterstock

Mutual Funds

Social Media

Elon Musk Bought X For $44B, Now Fidelity Values Social Media Network Below $10B

WIIM

The Pennant Group shares are trading lower after the company announced a public offering consisting of 3.5 million shares.

The Viridian Capital Credit Ranking Model utilizes eleven different bespoke financial and market variables to resolve four critical credit factors: Liquidity, Leverage, Profitability, and Size. These Factors are weighted to arrive at a credit score and credit rank. The use of market equity prices in several of our ratios makes our model dynamic, reacting instantly to new information driving stock prices rather than remaining fixed between earnings releases. The Viridian model provides a substitute for the credit ratings that are not yet available for cannabis companies and represents a valuable selection and monitoring tool for both debt and equity investors.
<ul>
<li>
The graph shows the updated Viridian Capital Credit Rankings of the top 31 U.S. Cultivation and Retail companies. The black line shows our liquidity rank; the red indicates our leverage rank, and the green indicates our overall ranking. The blue squares depict the yield at which the respective company&#39;s debt is offered. The numbers below the ticker symbols show the positive or negative changes in model rankings from the prior week.&nbsp; See this coming week&rsquo;s Viridian Credit Tracker for more detail on the indicators used in the model.&nbsp;
</li>
<li>
<img alt="untitled_design_23.png" src="https://www.benzinga.com/files/images/2024/September/30/untitled_design_23.png" style="height:549px; width:624px" />
</li>
</ul>
<h3>What&#39;s New?</h3>
<ul>
<li>
Last week&#39;s Chart introduced a pair of new valuation and leverage metrics that we believe are superior to traditional measures, taking into account important aspects of the MSO financial landscape, including accrued and unpaid 280e taxes and the preponderance of lease obligations in the capital structure of many competitors.&nbsp;&nbsp;
</li>
<li>
We have now incorporated several of these ratios into our credit model. Our leverage measures now include Adjusted Net Debt/ 2025 Estimated EBITDAR after making the following adjustments.&nbsp;
<ul>
<li>
Leases:&nbsp; our model always incorporated leases as debt through our most powerful leverage ratio, Total Liabilities to Market Cap; however, our updated model utilizes an Adjusted Net Debt/2025 EBITDAR estimate, where the debt includes all leases.
</li>
<li>
Taxes:&nbsp; We have also included as debt any accrued tax liabilities (including those in long-term, uncertain tax liability accounts) in excess of ninety days of tax expense. It is clear that several prominent cannabis companies are utilizing unpaid debt as a financing source, and our model now reflects that reality.
</li>
<li>
Rent Expense:&nbsp; Since rent has already been deducted from EBITDA, we add back the estimated rent expense to calculate Earnings Before Interest, Taxes, Depreciation, and Rent. Our Adjusted Net Debt/ EBITDAR ratio is agnostic to whether a company finances itself through leases or debt.
</li>
</ul>
</li>
<li>
Our Profitability indicators now include 2024 estimated EBITDAR/revenues, a measure that is unbiased in terms of whether companies lease or borrow.&nbsp;
</li>
</ul>
<h3>Will More Changes Be Coming?</h3>
We are constantly working on potential improvements to the model. Several changes under consideration include the addition of indicators for management changes, late financial statements, and an explicit consideration of the volatility of the market cap. We welcome user feedback and suggestions.
The Viridian Capital Chart of the Week highlights key investment, valuation and M&amp;A trends taken from the Viridian Cannabis Deal Tracker.
The <a href="https://viridianca.us1.list-manage.com/track/click?u=078ead34a8bbcfd77b0486326&amp;id=c89a19f9ee&amp;e=2699f9b787">Viridian Cannabis Deal Tracker</a> provides the market intelligence that cannabis companies, investors, and acquirers utilize to make informed decisions regarding capital allocation and M&amp;A strategy. The Deal Tracker is a proprietary information service that monitors capital raise and M&amp;A activity in the legal cannabis, CBD, and psychedelics industries. Each week the Tracker aggregates and analyzes all closed deals and segments each according to key metrics:
<ul>
<li>
Deals by Industry Sector (To track the flow of capital and M&amp;A Deals by one of 12 Sectors - from Cultivation to Brands to Software)
</li>
<li>
Deal Structure (Equity/Debt for Capital Raises, Cash/Stock/Earnout for M&amp;A) Status of the company announcing the transaction (Public vs. Private)
</li>
<li>
Principals to the Transaction (Issuer/Investor/Lender/Acquirer) Key deal terms (Pricing and Valuation)
</li>
<li>
Key Deal Terms (Deal Size, Valuation, Pricing, Warrants, Cost of Capital)
</li>
<li>
Deals by Location of Issuer/Buyer/Seller (To Track the Flow of Capital and M&amp;A Deals by State and Country)
</li>
<li>
Credit Ratings (Leverage and Liquidity Ratios)
</li>
</ul>
Since its inception in 2015, the Viridian Cannabis Deal Tracker has tracked and analyzed more than 2,500 capital raises and 1,000 M&amp;A transactions totaling over $50 billion in aggregate value.
The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

Cannabis Chart Of The Week: Introducing The Improved Viridian Capital Credit Ranking Model

ZKIN

ZK International shares are trading higher after the company reported a year-over-year increase in H1 revenue results.

Effective October 1, 2024, the Company is combining the management of its Engineered Materials, Plastics Solutions and Polystyrene businesses, resulting in a reduction in workforce due to the consolidation of business management roles and support functions.
These actions began in the&nbsp;third quarter&nbsp;of 2024 and are anticipated to be substantially complete by the end of 2025. The expected annualized run rate cost savings is&nbsp;$30 million&nbsp;with approximately&nbsp;$25 million&nbsp;realized in 2025 and the full run rate achieved by the end of 2026.
Additionally, the Company has decided to exit virgin polycarbonate production at its Stade, Germany production facility following discussions with the relevant works councils. Production is anticipated to end by January 2025 with severance and related benefit payments expected to complete by the end of 2026.
Once operations have ceased, all the Company&#39;s polycarbonate needs for its downstream, differentiated compounded products will be purchased from external suppliers, including its licensees, with the exception of its dissolution-based polycarbonate production. This purchasing change is expected to result in an annualized run rate profitability improvement of&nbsp;$15 million&nbsp;to&nbsp;$20 million&nbsp;relative to manufacturing at Stade.
The Company expects to record total pre-tax restructuring charges of&nbsp;$23 million&nbsp;to&nbsp;$28 million, principally comprised of&nbsp;$22 million&nbsp;to&nbsp;$26 million&nbsp;of severance and related benefit costs and&nbsp;$1 million&nbsp;to&nbsp;$2 million&nbsp;of asset-related and contract termination charges, primarily related to the virgin polycarbonate manufacturing site in Stade, Germany.

Trinseo Plans Restructuring Initiatives For Longer-Term Growth, Improved Profitability And Increased Cash Generation; To Exit Virgin Polycarbonate Production At Its Stade, Germany Production Facility

Dorchester Minerals, L.P. (the "Partnership") (NASDAQ-DMLP) announced today it has completed two previously announced acquisitions of mineral, royalty and overriding royalty interests. &nbsp;
The transactions were both structured as non-taxable contribution and exchanges.
In one transaction, the contributing entities conveyed their interests to the Partnership in exchange for 6,721,144 common units representing limited partnership interests in Dorchester Minerals, L.P.
In a separate transaction, the contributing entity conveyed its interests to the Partnership in exchange for 530,000 common units representing limited partnership interests in Dorchester Minerals, L.P.
Dorchester Minerals, L.P. is a Dallas based owner of producing and non-producing oil and natural gas mineral, royalty, overriding royalty, net profits, and leasehold interests located in 28 states. Its common units trade on the NASDAQ Global Select Market under the symbol DMLP.

DMLP

Dorchester Minerals, L.P. Announces 2 Acquisitions Of Mineral, Royalty And Overriding Royalty Interests; No Financial Terms Disclosed

NITO

N2OFF shares are trading higher after the company announced updates for its Solar PV joint venture with Solterra Renewable Energy.

Pebblebrook Hotel Trust Reports Impact Of Hurricane Helene; Expects Repair And Remediation Costs Net Of Insurance Payments Not To Be Material

ZK International Gr Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZKIN#NASDAQ">ZKIN</a>) reported quarterly losses of $(0.01) per share. The company reported $52.89 million in sales this quarter. This is a 6.50 percent increase over sales of $49.66 million the same period last year.

Earnings

ZK International Gr Co H1 EPS $(0.01), Sales $52.89M Up From $49.66M YoY

Biggest stock movers Monday: Chinese stocks, and more

Shares of Stellantis ($STLA) plummeted in pre-market trading after the French-Italian automaker slashed its FY24 forecast and warned of higher-than...

Stellantis (NYSE:STLA) Tumbles After Slashing  Guidance and Warning of Cash Burn

J.P. Morgan analyst Jose Asumendi maintained a Buy rating on Stellantis (STLA – Research Report) today and set a price target of €20.00. The compan...

Stellantis (STLA) Gets a Buy from J.P. Morgan

In a report released today, Colin Langan from Wells Fargo maintained a Sell rating on Stellantis (STLA – Research Report), with a price target of €...

Stellantis (STLA) Receives a Sell from Wells Fargo

Deutsche Bank analyst Tim Rokossa maintained a Hold rating on Stellantis (STLA – Research Report) today and set a price target of €23.00. The compa...

Deutsche Bank  Sticks to Their Hold Rating for Stellantis (STLA)

Biggest stock movers Monday: Chinese, crypto stocks, and more

The auto sector is jolted by gloomy updates out of Europe

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Nike (NKE – Research Report) and Stellantis (STLA – Resear...

Analysts Have Conflicting Sentiments on These Consumer Cyclical Companies: Nike (NKE) and Stellantis (STLA)

Stellantis (IT:STLAM) has released an update. Stellantis N.V. has actively pursued its share buyback program, repurchasing a total of 6,792,123 com...

Stellantis Advances Share Buyback Strategy

Investing in value stocks is appealing now due to their strong long-term performance and affordability, as interest rates decline and inflation stabilizes, providing a lower-risk opportunity before Wall Street takes notice. Hence, it may be wise to add fundamentally strong value stocks like Stellantis (STLA), Centene (CNC), and Cardinal Health (CAH) to one's portfolio now. Read on… Value stocks are increasingly attractive now due to their historically strong long-term performance, especially as interest rates decline. With inflation stabilizing and many stocks facing potential overvaluation, value stocks present a lower-risk opportunity for investors seeking reliable returns.
Therefore, investors could consider buying fundamentally strong value stocks such as Stellantis N.V. (<a href="https://stocknews.com/stock/STLA/">STLA</a>), Centene Corporation (<a href="https://stocknews.com/stock/CNC/">CNC</a>), and Cardinal Health, Inc. (<a href="https://stocknews.com/stock/CAH/">CAH</a>) for their discounted valuations and solid fundamentals, before Wall Street catches on.
U.S. inflation is decelerating, contributing to economic stability. Gross domestic product (GDP) grew at an annualized <a href="https://www.reuters.com/markets/us/us-second-quarter-economic-growth-unrevised-gdi-revised-sharply-higher-2024-09-26/">3.0% in Q2 2024</a>, while gross domestic income (GDI) surged to a revised 3.4%. These positive trends reflect a balanced economic environment with improved corporate profits, reduced inflationary pressures, and stronger consumer spending.
Despite ongoing uncertainties, the recent <a href="https://www.forbes.com/advisor/investing/fed-rate-cut-impact-prices/">50 basis point rate cut</a> by the Fed has the potential to foster greater economic stability, increase profits through reduced borrowing costs, and enhance investor confidence. This environment makes undervalued stocks particularly appealing, as they stand to gain from improved earnings potential and a more positive market sentiment.
Considering these trends, let's assess the fundamentals of the abovementioned value stocks.
Stellantis N.V. (<a href="https://stocknews.com/stock/STLA/">STLA</a>)
Headquartered in Hoofddorp, the Netherlands, STLA designs, manufactures, distributes, and sells automobiles and light commercial vehicles, engines, transmission systems, metallurgical products, mobility services, and production systems worldwide.
On September 30, 2024, STLA announced that Leapmotor International has opened orders for the T03 and C10 electric vehicles in Europe through STLA's brand dealers. This joint venture aims to expand global sales of affordable, high-tech electric vehicles, with deliveries expected later this year.
On September 17, 2024, STLA inaugurated its global commercial vehicles hub at Mirafiori Automotive Park 2030 in Turin, Italy, to streamline cross-brand functions and strengthen leadership in the commercial vehicle market. STLA Pro One aims to enhance efficiency and global operations, with commercial vehicles accounting for one-third of the company's total net revenue.
In terms of forward non-GAAP <a href="https://www.investopedia.com/terms/p/price-earningsratio.asp">P/E</a>, STLA's 3.48x is 80% lower than the 17.39x industry average. Its 1.57x forward EV/EBITDA is 84.8% lower than the 10.36x industry average. Likewise, its 2.28x forward EV/EBIT is 85.2% lower than the 15.44x industry average.
STLA's net revenues for the first half ended June 30, 2024, stood at €85.02 billion ($94.91 billion). Its net profit attributable to the owners of the parent was €5.62 billion ($6.27 billion), and its adjusted operating income came in at €8.46 billion ($9.44 billion). Furthermore, the company's adjusted EPS was €2.36.
Street expects STLA's EPS and revenue for fiscal 2025 to increase 12.6% and 4.9% year-over-year to $5.20 and $196.98 billion, respectively. Over the past month, the stock has declined 4.3% to close the last trading session at $16.06.
STLA's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect robust prospects. It has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.
STLA is ranked #14 out of 54 stocks in the <a href="https://stocknews.com/category/auto-vehicle-makers/">Auto &amp; Vehicle Manufacturers</a> industry. It has an A grade for Value and a B for Stability. To see STLA's Growth, Momentum, Sentiment, and Quality ratings, <a href="https://stocknews.com/stock/STLA/">click here</a>.
Centene Corporation (<a href="https://stocknews.com/stock/CNC/">CNC</a>)
CNC operates as a healthcare enterprise that provides programs and services to underinsured and uninsured families, commercial organizations, and military families. The company operates through segments including Medicaid, Medicare, Commercial, and Other.
On September 23, 2024, CNC's subsidiary, Health Net, was selected to provide managed dental care services for Medi-Cal beneficiaries in Los Angeles and Sacramento counties under a new 54-month contract starting July 1, 2025. Health Net will serve nearly 385,000 members in these counties.
On September 4, 2024, CNC's subsidiary, Iowa Total Care, was awarded a four-year statewide Medicaid contract by the Iowa Department of Health and Human Services to continue providing Medicaid managed care services under the Iowa Health Link program. The contract begins July 1, 2025, with a potential two-year extension.
In terms of forward non-GAAP PEG, CNC's 1.38x is 30.1% lower than the 1.97x industry average. Likewise, its 10.92x forward non-GAAP P/E is 49.9% lower than the 21.78x industry average. Also, its 0.25x forward EV/Sales is 93.2% lower than the 3.69x industry average.
In the fiscal second quarter that ended June 30, 2024, CNC's total revenues rose 5.9% year-over-year to $39.84 billion. Likewise, its earnings from operations rose 5% from the year-ago value to $1.23 billion. The company's adjusted net earnings and adjusted EPS increased 11.1% and 15.2% over the prior-year quarter to $1.28 billion and $2.42, respectively.
For the quarter ending September 30, 2024, CNC's revenue is expected to increase marginally year-over-year to $38.08 billion. Its EPS for the quarter ending December 31, 2024, is expected to rise 45.8% year-over-year to $0.66. CNC surpassed the Street EPS estimates in each of the trailing four quarters. Over the past three months, the stock has gained 10.7% to close the last trading session at $74.58.
CNC's strong fundamentals are reflected in its POWR Ratings. It has an overall rating of A, which translates to a Strong Buy in our proprietary rating system.
It has an A grade for Value and a B for Growth and Quality. Within the A-rated <a href="https://stocknews.com/category/health-insurance/">Medical - Health Insurance</a> industry, it is ranked #2 out of 10 stocks. To access the additional POWR Ratings of CNC for Momentum, Stability, and Sentiment, <a href="https://stocknews.com/stock/CNC/">click here</a>.
Cardinal Health, Inc. (<a href="https://stocknews.com/stock/CAH/">CAH</a>)
CAH operates as a healthcare services and products company internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and home-based patients. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.
On September 20, 2024, CAH announced its agreement to acquire Integrated Oncology Network (ION) for $1.12 billion in cash. The acquisition will expand CAH's Navista oncology practice alliance, adding over 100 providers across more than 50 community-based sites in 10 states.
On August 21, 2024, CAH announced plans to open a new 249,000-square-foot distribution center in Walton Hills, Ohio, by spring 2025. The facility will feature advanced technology and automation to enhance medical product distribution efficiency and customer service.
In terms of forward Price/Sales, CAH's 0.12x is 96.8% lower than the 3.78x industry average. Its 10.53x forward EV/EBIT is 37.6% lower than the 16.89x industry average. Likewise, its 14.40x forward non-GAAP P/E is 33.9% lower than the 21.78x industry average.
CAH's revenue for the fourth quarter, which ended on June 30, 2024, increased 12.1% year-over-year to $59.87 billion. Its non-GAAP gross margin rose 5.5% over the prior-year quarter to $1.88 billion. For the same quarter, the company's non-GAAP net earnings and non-GAAP EPS were $450 million and $1.84, respectively, up by 22.6% and 28.7% compared to the prior-year quarter.
Analysts expect CAH's EPS for the quarter ending March 31, 2025, to increase 5% year-over-year to $2.18. Its revenue for fiscal 2026 is expected to grow 8.2% year-over-year to $234.25 billion. It surpassed the consensus EPS estimates in each of the trailing four quarters. Over the past year, CAH's stock has gained 24.7% to close the last trading session at $109.79.
CAH's POWR Ratings reflect this positive outlook. CAH has an overall rating of A, which translates to a Strong Buy in our proprietary rating system.
It has an A grade for Growth and Value and a B for Stability. Within the <a href="https://stocknews.com/category/medical-services/">Medical - Services</a> sector, it is ranked #3 out of 60 stocks. To access additional grades for CAH's Momentum, Sentiment, and Quality, <a href="https://stocknews.com/stock/CAH/">click here</a>.
What To Do Next?
43 year investment veteran, Steve Reitmeister, has just released his 2024 market outlook along with trading plan and top 11 picks for the year ahead.
<a href="https://report.stocknews.com/sign-up/stock-market-outlook-2024/?formplacement=artbotad_smo24_rep">2024 Stock Market Outlook &gt;</a>

<hr />
STLA shares were trading at $13.96 per share on Monday afternoon, down $2.10 (-13.08%). Year-to-date, STLA has declined -40.14%, versus a 21.21% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Abhishek Bhuyan</h2> <img src='https:/wp-content/uploads/2023/07/ABhuyan.jpg' style="float:left; padding:5px;width:125px;">Abhishek embarked on his professional journey as a financial journalist due to his keen interest in discerning the fundamental factors that influence the future performance of financial instruments.<a href="https://stocknews.com/authors/?author=abhishek-bhuyan">More...</a>The post <a href=https://stocknews.com/news/stla-cnc-cah-3-value-stocks-to-buy-now-before-wall-street-catches/>3 Value Stocks to Buy Now Before Wall Street Catches On</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Value Stocks to Buy Now Before Wall Street Catches On

ADNT

AMGDF

APTV

ARGGY

BABA

BIDU

BITF

BTBT

COIN

GNTX

MARA

MSTR

NTES

PHIN

RIOT

VLKAF

VWAGY

Legal

Press Releases

STLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Stellantis N.V. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Stellantis N.V.  - STLA

ROSEN, A RANKED AND LEADING FIRM, Encourages Stellantis N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STLA

STELLANTIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Stellantis N.V. - STLA

STLA Investors Have Opportunity to Lead Stellantis N.V. Securities Fraud Lawsuit

Faruqi & Faruqi Reminds Stellantis Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024 - STLA

Stellantis Updates 2024 Financial Guidance

Stellantis N.V. Class Action: The Gross Law Firm Reminds Stellantis Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024 - STLA

Leapmotor International Opens Orders in Europe for Affordable, High-Tech T03 City Car and C10 SUV Electric Vehicles

Shareholders that lost money on Stellantis N.V.(STLA) should contact Levi & Korsinsky about pending Class Action - STLA

PARIS:STLAP

Jefferies

Bernstein

Morgan Stanley

Piper Sandler

Stellantis shares are trading lower after the company lowered its FY24 guidance.

Comments

Stellantis

Vendite allo scoperto

Stellantis (NYSE:STLA) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO